---
title: "Aoshikang Technology Co., Ltd.: Adjusted the upper limit of the share repurchase price to 53.35 yuan/share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252654507.md"
description: "Aoshikang Technology Co., Ltd. announced that the upper limit for the share repurchase price will be adjusted from RMB 39.40 per share to RMB 53.35 per share. This adjustment is based on confidence in the company's future development. Apart from the adjustment of the upper limit price, other details of the repurchase plan remain unchanged, and the price limit adjustment will take effect from August 13, 2025"
datetime: "2025-08-12T10:52:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252654507.md)
  - [en](https://longbridge.com/en/news/252654507.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252654507.md)
generator: "portal-rs"
---

# Aoshikang Technology Co., Ltd.: Adjusted the upper limit of the share repurchase price to 53.35 yuan/share

Aoshikang Technology Co., Ltd. announced that the upper limit for the share repurchase price will be adjusted from RMB 39.40 per share to RMB 53.35 per share. This adjustment is based on confidence in the company's future development. Aside from the adjustment of the upper limit price, other contents of the repurchase plan remain unchanged, and the price limit adjustment will take effect from August 13, 2025

### Related Stocks

- [002913.CN](https://longbridge.com/en/quote/002913.CN.md)

## Related News & Research

- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)
- [INGENIC  Starts HK IPO Today; Entry Fee HKD10.4K; 11 Cornerstone Investors Introduced](https://longbridge.com/en/news/296044028.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md)
- [PFSE: Record Q2 revenue and profit growth, driven by strong demand and innovation in HVDC technology](https://longbridge.com/en/news/296308264.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**